(loteprednol etabonate ophthalmic gel) 0.38%
LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% is used to treat inflammation and pain following eye surgery.
(loteprednol etabonate ophthalmic suspension) 0.5%
LOTEMAX® (loteprednol etabonate ophthalmic suspension) 0.5% is used to treat inflammatory and allergic conditions of the conjunctiva (outer eye membrane) that respond to steroids. It is also used to treat inflammation following eye surgery.
More Information
(loteprednol etabonate ophthalmic gel) 0.5%
LOTEMAX® GEL (loteprednol etabonate ophthalmic gel) 0.5% is used to treat inflammation and pain following eye surgery.
More Information
(loteprednol etabonate ophthalmic ointment) 0.5%
LOTEMAX® Ointment (loteprednol etabonate ophthalmic ointment) 0.5% is used to treat inflammation and pain following eye surgery.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here for full Prescribing Information for LOTEMAX® SM.
You are encouraged to report negative side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
Please click here for full Prescribing Information for LOTEMAX®.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here for full Prescribing Information for LOTEMAX® Gel.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here for full Prescribing Information for LOTEMAX® Ointment.
The website you are about to visit is not affiliated with Bausch + Lomb Incorporated. Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to enter and does not monitor non-affiliated websites for accuracy. Links to non-affiliated websites are provided as a convenience; they do not constitute an endorsement or support of any programs, products, or services associated with the website.